Gut-Targeted treatment shows promise for taming type 1 diabetes
NCT ID NCT03999853
Summary
This small study tested whether delivering butyrate—a natural compound—directly to the colon could help people with type 1 diabetes. Researchers wanted to see if this approach could make the body respond better to insulin and lower blood fat levels. Six adults with type 1 diabetes took the special tablets for eight weeks while their insulin sensitivity and triglyceride levels were measured.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.